Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin for Ventilator-associated Pneumonia
NCT01865266Phase 3Unknown
- Sponsor
- Shanghai Minhang District Central Hospital
- Start
- Jan 2014
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of ulinastatin in ventilator-associated pneumonia (VAP), sponsored by Shanghai Minhang District Central Hospital. Status: unknown.
02
Drugs
ulinastatin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT01865266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01865266.